Cover Image

Commentary on the T1D exchange quality improvement collaborative learning session November 2023 abstracts

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Shideh Majidi, Shivani Agarwal, Nicole Rioles, Robert Rapaport, Osagie Ebekozien
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Journal of Diabetes
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Commentary on the T1D Exchange Quality Improvement Collaborative Learning Session November 2025 Abstracts
by: Stephanie S. Crossen, et al.
Published: (2026)

Technology and health inequities in diabetes care: How do we widen access to underserved populations and utilize technology to improve outcomes for all?
by: Osagie Ebekozien, et al.
Published: (2024)

Feasibility of caregiver diabetes distress screening in routine clinical care of youth with type 1 diabetes
by: Einas H. Alkhatib, et al.
Published: (2024)

November 11–12, 2025, T1DX‐QI Learning Session, Journal of Diabetes
Published: (2026)

Response to Commentary on “A Population‐Based Correlation Analysis Between Hemoglobin A1c and Hemoglobin Levels”
by: Tingyu Zhang, et al.
Published: (2025)

Body mass index moderates the association between diabetes distress and objective self‐management behaviours in adolescents with type 1 diabetes and elevated A1Cs
by: Paige J. Trojanowski, et al.
Published: (2024)

Commentary on “Protective Effect of Regular Physical Activity Against Diabetes‐Related Lower Extremity Amputation”
by: Zeinab Mohseni Afshar, et al.
Published: (2025)

Commentary on “Pedal Medial Arterial Calcification in Diabetic Foot Ulcers: A Significant Risk Factor of Amputation and Mortality”
by: Mostafa Javanian, et al.
Published: (2025)

The 2023 WCIRDC: Obesity
by: Zachary T. Bloomgarden
Published: (2024)

Commentary on “Intra‐islet α‐cell Gs signaling promotes glucagon release”
by: Tadahiro Kitamura
Published: (2024)

Commentary on “Factors associated with diabetic foot ulcers and lower limb amputations in type 1 and type 2 diabetes supported by real‐world data from the German/Austrian DPV registry”
by: Mostafa Javanian, et al.
Published: (2024)

Response to “Commentary on factors associated with diabetic foot ulcers and lower limb amputations in type 1 and type 2 diabetes supported by real‐world data from the German/Austrian DPV registry”
by: Alexander J. Eckert, et al.
Published: (2024)

Response to Commentary on “Sleep Phenotypes, Genetic Susceptibility, and Risk of Obesity in Patients With Type 2 Diabetes: A National Prospective Cohort Study”
by: Lei Xi, et al.
Published: (2025)

Commentary on “Association of Serum Total Bilirubin to Cholesterol Ratio With Progression of Chronic Kidney Disease in Patients With Type 2 Diabetes: A Retrospective Cohort Study”
by: Tinghua Zhang
Published: (2025)

Response to Commentary on ‘Diminished levels of insulin‐like growth factor‐1 may be a risk factor for peripheral neuropathy in type 2 diabetes patients’
by: Jingyi Zhong, et al.
Published: (2025)

Commentary on “Effectiveness of tele‐guidance for physiotherapy in older patients with type 2 diabetes: A randomized controlled trial”
by: Ying Zhou, et al.
Published: (2025)

Commentary on “Liver function effects of SGLT2 inhibitor and GLP ‐1 receptor agonist combination treatment in patients with type 2 diabetes ( post hoc analysis of RECAP study)”
by: Yu Zhang, et al.
Published: (2025)

Management of diabetic ketoacidosis in children: Does early insulin glargine help improve outcomes?
by: Rebecca Ohman‐Hanson, et al.
Published: (2024)

Commentary on “Prevalence, incidence, and risk factors of diabetic retinopathy and macular edema in patients with early and late‐onset type 2 diabetes mellitus”
by: Fatemeh Rasulpur, et al.
Published: (2025)

Commentary on “Prognostic value of longitudinal HbA1c variability in predicting the development of diabetic sensorimotor polyneuropathy among patients with type 2 diabetes mellitus: A prospective cohort observational study”
by: Fatemeh Rasulpur, et al.
Published: (2025)

Optimizing lipid control in Taiwanese diabetic patients: A collaborative consensus by the Diabetes Association of the Republic of China (Taiwan) and the Taiwanese Association of Diabetes Educators
by: Feng‐Chih Shen, et al.
Published: (2024)

Commentary on: Inhibition of LINC00707 / miR ‐223‐3p/ FKBP5 axis has a protective effect on diabetic kidney disease
by: Yirui Zhao, et al.
Published: (2025)

Updates in Type 1 Diabetes ( T1D ): What Recent Findings Might Mean for Treatment and Prevention Strategies
by: Zachary Bloomgarden
Published: (2026)

Further learning of clinical characteristics and imaging manifestations of nonketotic hyperglycemic hemichorea
by: Xiaoyu Wang, et al.
Published: (2024)

Advances in insulin pump systems lead to stepwise improvements in treatment satisfaction in people with type 1 diabetes: A single‐center retrospective study
by: Naoya Shimizu, et al.
Published: (2025)

New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version)
by: Akira Shimada, et al.
Published: (2024)

Oral abstracts
Published: (2024)

Poster abstracts
Published: (2024)

Oral abstracts
Published: (2025)

A machine learning approach to predicting severe diabetes distress in adults with type 1 diabetes mellitus
by: Naoki Sakane, et al.
Published: (2026)

Comment on “A machine learning approach to predicting severe diabetes distress in adults with type 1 diabetes mellitus”
by: Yindan Song, et al.
Published: (2026)

Identifying Promising Immunomodulators for Type 1 Diabetes (T1D) and Islet Transplantation
by: Nida Ajmal, et al.
Published: (2024)

Oral presentation abstracts
Published: (2026)

Poster award abstracts
Published: (2026)

Targeting PI3K/AKT and MEK/ERK pathways for synergic effects on improving features of peripheral diabetic neuropathy
by: Vuong M. Pham
Published: (2024)

Deciphering the connection: Diabetes, pericyte dysfunction, and their impact on cardiovascular health
by: Robert Chilton, et al.
Published: (2024)

Calpeptin improves the cognitive function in Alzheimer's disease‐like complications of diabetes mellitus rats by regulating TXNIP/NLRP3 inflammasome
by: Luyao Qiao, et al.
Published: (2024)

Mitochondrial ALDH2 improves ß‐cell survival and function against doxorubicin‐induced apoptosis by targeting CK2 signaling
by: Udayakumar Karunakaran, et al.
Published: (2024)

Imeglimin improves hyperglycemia and hypoglycemia‐induced cell death and mitochondrial dysfunction in immortalized adult mouse Schwann IMS32 cells
by: Ayako Kato, et al.
Published: (2025)

Correction to “Association between variation in hemoglobin A1c levels and diabetes therapy‐related quality of life in patients with diabetes”
Published: (2024)